U

Surgalign Holdings, Inc.

NASDAQ
Recommendation
Dividend Power Score
Latest Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)

03/31/2023 12/31/2022 09/30/2022 06/30/2022 03/31/2022
Net Income 5.17% 20.24% 50.58% -- --
Total Depreciation and Amortization 12.29% 18.26% 826.85% -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -100.90% -89.51% -83.71% -- --
Change in Net Operating Assets 164.51% 41.21% 39.90% -- --
Cash from Operations -69.44% -158.34% -120.71% -- --
Capital Expenditure 29.95% 37.17% 9.34% -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 84.42% -- --
Divestitures -- -- -- -- --
Other Investing Activities -2.39% 4.81% 86.94% -- --
Cash from Investing 164.38% 55.46% 70.18% -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -38.90% -21.95% -49.82% -- --
Repurchase of Common Stock -26.47% 58.96% 56.47% -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- -10,639.47% -- --
Cash from Financing -21.38% -32.89% -60.98% -- --
Foreign Exchange rate Adjustments -173.45% -118.36% -19.30% -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 9.49% -2,011.09% -65.58% -- --